Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 44 th Annual J.P. Morgan...
2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky
1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in...
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up by +0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.20%. December...
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
The S&P 500 Index ($SPX ) (SPY ) today is up by +0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.06%. December E-mini S&P...
The S&P 500 Index ($SPX ) (SPY ) today is down by -0.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.49%. December E-mini S&P...
/Vertex%20Pharmaceuticals%2C%20Inc_%20HQ%20in%20Boston-by%20Tada%20Images%20via%20Shuttershock.jpg)
Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.